136 related articles for article (PubMed ID: 8431892)
1. Primary treatment of epithelial ovarian malignancies.
McGuire WP
Cancer; 1993 Feb; 71(4 Suppl):1541-50. PubMed ID: 8431892
[No Abstract] [Full Text] [Related]
2. [Chemotherapy of epithelial ovarian carcinoma].
Bruntsch U; Gallmeier WM
MMW Munch Med Wochenschr; 1983 Nov; 125(44):993-5. PubMed ID: 6417517
[No Abstract] [Full Text] [Related]
3. [Chemotherapy in 143 advanced epithelial cancers of the ovary. Experience at the Hôtel-Dieu of Quebec and Hôpital Saint-Antoine (Paris)].
de Gramont A; Drolet Y; Louvet C; Dray C; Krulik M; Pigné A; Lavoie A; Painchaud M; Blouin R; Tessier C
J Gynecol Obstet Biol Reprod (Paris); 1986; 15(1):105-9. PubMed ID: 3084619
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy of advanced epithelial ovarian carcinoma].
Meerpohl HG
Onkologie; 1984 May; 7 Suppl 2():22-34. PubMed ID: 6431349
[TBL] [Abstract][Full Text] [Related]
6. Randomized comparison of hexamethylmelamine, adriamycin, cyclophosphamide (HAC) vs. cisplatin, adriamycin, cyclophosphamide (PAC) in advanced ovarian cancer: long-term results.
Sessa C; Colombo N; Bolis G; Marsoni S; Mangioni C
Cancer Treat Rev; 1991 Mar; 18 Suppl A():37-46. PubMed ID: 1904308
[No Abstract] [Full Text] [Related]
7. Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO III and IV) as measured by surgical end-staging (second-look surgery)--the mount sinai experience.
Cohen CJ; Bruckner HW; Goldberg JD; Holland JF
Clin Obstet Gynaecol; 1983 Aug; 10(2):307-24. PubMed ID: 6413114
[No Abstract] [Full Text] [Related]
8. [Chemotherapy in advanced forms of carcinoma of the ovary].
Calciati A; Clerico M; Donadio M; Giaccone G
Minerva Ginecol; 1984 Apr; 36(4):195-8. PubMed ID: 6431334
[No Abstract] [Full Text] [Related]
9. Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration.
Hainsworth JD; Grosh WW; Burnett LS; Jones HW; Wolff SN; Greco FA
Ann Intern Med; 1988 Feb; 108(2):165-70. PubMed ID: 3124679
[TBL] [Abstract][Full Text] [Related]
10. The sequential multiple modality treatment of ovarian cancer.
Dembo AJ
Radiother Oncol; 1985 Apr; 3(3):187-92. PubMed ID: 3923573
[No Abstract] [Full Text] [Related]
11. [Intraoperative chemotherapy with mitoxantrone and cisplatin after extensive debulking in the treatment of stage III and IV epithelial neoplasms of the ovaries].
Griggio L; Tasinato R
Tumori; 1999; 85(3 Suppl 1):S49-51. PubMed ID: 10542889
[No Abstract] [Full Text] [Related]
12. Chemotherapy of drug-resistant ovarian cancer: a Southwest Oncology Group Study.
Laufman LR; Green JB; Alberts DS; O'Toole R; Hilgers RD; Young DC; Lin F; Rivkin SE
J Clin Oncol; 1986 Sep; 4(9):1374-9. PubMed ID: 3091778
[TBL] [Abstract][Full Text] [Related]
13. Ovarian cancer: what is poor prognosis disease?
Cohen MH
J Clin Oncol; 1990 Jul; 8(7):1287-8. PubMed ID: 2113572
[No Abstract] [Full Text] [Related]
14. [Chemotherapy of epithelial ovarian cancer: CHexUP versus thio-tepa].
Wu BZ
Zhonghua Fu Chan Ke Za Zhi; 1987 Jan; 22(1):5-8, 61. PubMed ID: 3109851
[No Abstract] [Full Text] [Related]
15. Radiotherapeutic management of ovarian cancer.
Dembo AJ
Semin Oncol; 1984 Sep; 11(3):238-50. PubMed ID: 6435249
[No Abstract] [Full Text] [Related]
16. Use of cis-platinum in the treatment of ovarian carcinoma. Clinical results and evaluation of nephrotoxicity.
Giannattasio M; Rizzi R; Coratelli P; Restaino A; Selvaggi L; Ferreri R; Orlando E; Ierardi GM; Granata A; Bettocchi S
Eur J Gynaecol Oncol; 1983; 4(1):41-3. PubMed ID: 6407837
[No Abstract] [Full Text] [Related]
17. The role of chemotherapy in the management of celomic epithelial carcinoma of the ovary.
Thigpen T; Vance R; Khansur T; Malamud F
Cancer Invest; 1997; 15(3):277-87. PubMed ID: 9171863
[No Abstract] [Full Text] [Related]
18. Management of recurrent ovarian carcinoma.
Ang PT; Kavanagh J
Am J Clin Oncol; 1989 Jun; 12(3):269-72. PubMed ID: 2543208
[No Abstract] [Full Text] [Related]
19. [The potentials of combined chemotherapy in disseminated ovarian cancer].
Gorbunova VA; Perevodchikova NI; Kozachenko VP; Ryzhakov VM; Marenich AF; Zhordania KI
Akush Ginekol (Mosk); 1991 Feb; (2):54-7. PubMed ID: 1907433
[No Abstract] [Full Text] [Related]
20. The case for combination chemotherapy in the treatment of advanced ovarian cancer.
Ozols RF
J Clin Oncol; 1985 Nov; 3(11):1445-7. PubMed ID: 3932603
[No Abstract] [Full Text] [Related]
[Next] [New Search]
